Trial
NCT04749433
Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Johns Hopkins University
Collaborators
Precision Molecular
Condition
Amyotrophic Lateral Sclerosis
Intervention
[11C]CPPC Injection
Why stopped
study stopped to enhance protocol and resume under different sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-08